Hypoglycaemia and hypoxic–ischaemic encephalopathy

Publisher： John Wiley & Sons Inc

ISSN： 0012-1622

Source： DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol.57, Iss.S3, 2015-04, pp. : 29-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erythropoietin: a novel therapy for hypoxic–ischaemic encephalopathy?

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 34-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does aetiology of neonatal encephalopathy and hypoxic–ischaemic encephalopathy influence the outcome of treatment?

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 2-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neonatal seizures in hypoxic–ischaemic encephalopathy – risks and benefits of anticonvulsant therapy

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 40-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

The long‐term health, social, and financial burden of hypoxic–ischaemic encephalopathy

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 48-50

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early predictors of outcome in infants treated with hypothermia for hypoxic–ischaemic encephalopathy

By  

DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Vol. 57, Iss. S3, 2015-04 ,pp. : 8-16

John Wiley & Sons Inc

Access to resources Recommend Favorite